Emgality is an injection with galcanezumab in its composition, which has already been approved in the United States of America, for the preventive treatment of migraine in adults.
This medicine, produced by Lilly laboratories, must be administered once a month, and the administration can be performed at home, by the person himself.
How to use
Emgality is an injection that should be given subcutaneously into the abdomen, thigh, back of the arm or buttocks. This injection can be administered at home, by the person himself, who must be properly trained to do so by a health professional.
The recommended dose is 240 mg given in two consecutive doses of 120 mg followed by monthly doses of 120 mg.
Who should not use
This medicine is contraindicated for people who are hypersensitive to any of the components of the formula.
In addition, it should also not be given to pregnant women, nursing mothers and children, as there are no studies to prove the safety of the drug in these cases.
The doctor should also be informed about any medicine the person is taking, in order to avoid drug interactions.
See other remedies that are used for the treatment of migraine.
Possible side effects
The most common side effects that can occur with the use of this medicine are reaction at the injection site.
In addition, although rare, an allergic reaction may occur with symptoms such as swelling of the face, mouth, tongue, and throat, and difficulty breathing.
